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1. Introduction 
Probiotic bacteria are used in production of functional foods and pharmaceutical products. 
They play an important role in promoting and maintaining human health. In order, to 
produce health benefits probiotic strains should be present in a viable form at a suitable 
level during the product is shelf life until consumption and maintain high viability 
throughout the gastrointestinal tract. Many reports indicated that there is poor survival of 
probiotic bacteria in products containing free probiotic cells [1]. Providing probiotic living 
cells with a physical barrier to resist adverse environmental conditions is therefore an 
approach currently receiving considerable interest [2]. 
The encapsulation techniques for protection of bacterial cells have resulted in greatly 
enhanced viability of these microorganisms in food products as well as in the 
gastrointestinal tract. Encapsulation is a process to entrap active agents within a carrier 
material and it is a useful tool to improve living cells into foods, to protect [3, 4, 5, 6, 7], to 
extend their storage life and to convert them into a powder form for convenient use [8, 9, 10, 
11]. In addition, encapsulation can promote controlled release and optimize delivery to the 
site of action, thereby potentiating the efficacy of the respective probiotic strain. This process 
can also prevent these microorganisms from multiplying in food that would otherwise 
change their sensory characteristics. Otherwise, materials used for design of protective shell 
of encapsulates must be food-grade, biodegradable and able to form a barrier between the 
internal phase and its surroundings. 
2. Probiotics 
2.1. Definition 
Probiotics are defined as live microorganisms which, when administered in adequate 
amounts, confer health benefits to the host [12], including inhibition of pathogenic growth, 
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maintenance of health promoting gut microflora, stimulation of immune system, relieving 
constipation, absorption of calcium, synthesis of vitamins and antimicrobial agents, and 
predigestion of proteins [13]. Several health benefits have been proved for specific 
probiotic bacteria, and recommendations for probiotic use to promote health have been 
published [14]. 
The term ‘‘probiotic’’ includes a large range of microorganisms, mainly bacteria but also 
yeasts. Because they can stay alive until the intestine and provide beneficial effects on the 
host health, lactic acid bacteria (LAB), non-lactic acid bacteria and yeasts can be considered 
as probiotics. LAB are the most important probiotic known to have beneficial effects on the 
human gastro-intestinal (GI) tract [15]. 
The effects of probiotics are strain-specific [16, 17, 18] and that is the reason why it is 
important to specify the genus and the species of probiotic bacteria when proclaiming 
health benefits. Each species covers various strains with varied benefits for health. The 
probiotic health benefits may be due to the production of acid and/or bacteriocins, 
competition with pathogens and an enhancement of the immune system [19]. Dose levels 
of probiotics depend on the considered strain [20], but 106–107 CFU/g of product per day is 
generally accepted [21]. 
2.2. Health benefits 
There is evidence that probiotics have the potential to be beneficial for our health [22]. 
Multiple reports have described their health benefits on gastrointestinal infections, 
antimicrobial activity, improvement in lactose metabolism, reduction in serum cholesterol, 
immune system stimulation, antimutagenic properties, anti-carcinogenic properties, anti-
diarrheal properties, improvement in inflammatory bowel disease and suppression of 
Helicobacter pylori infection by addition of selected strains to food products [23, 24, 25, 26, 
27, 28, 29, 30, 31, 32, 33]. 
The beneficial effects of probiotic microorganisms appear when they arrive in the intestinal 
medium, viable and in high enough number, after surviving the above mentioned harsh 
conditions [34]. The minimum number of probiotic cells (cfu/g) in the product at the 
moment of consumption that is necessary for the fruition of beneficial pharmaceutical 
(preventive or therapeutic) effects of probiotics has been suggested to be represented by 
the minimum of bio-value (MBV) index [35]. According to the International Dairy 
Federation (IDF) recommendation, this index should be ≥107 cfu/g up to the date of 
minimum durability [36]. Also, various recommendations have been presented by different 
researchers such as >106 cfu/g by all probiotics in yogurt [37, 38] and >107 cfu/g in the case 
of bifidobacteria [39]. Apart from the MBV index, daily intake (DI) of each food product is 
also determinable for their probiotic effectiveness. The minimum amount of the latter 
index has been recommended as approximately 109 viable cells per day [35, 38, 40].The 
type of culture media used for the enumeration of probiotic bacteria is also an important 
factor for determination of their viability, as the cell recovery rate of various media are 
different [35, 41]. 
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Most existing probiotics have been isolated from the human gut microbiota. This microbiota 
plays an important role in human health, not only due to its participation in the digestion 
process, but also for the function it plays in the development of the gut and the immune 
system [42]. The mechanisms of action of probiotic bacteria are thought to result from 
modification of the composition of the endogenous intestinal microbiota and its metabolic 
activity, prevention of overgrowth and colonization of pathogens and stimulation of the 
immune system [43]. With regard to pathogen exclusion, probiotic bacteria can produce 
antibacterial substances (such as bacteriocins and hydrogen peroxide), acids (that reduce the 
pH of the intestine), block adhesion sites and be competitive for nutrients [44]. 
Recent studies have shown differences in the composition of the gut microbiota of healthy 
subjects [45], underlining the difficulties in defining the normal microbiota at microbial 
species level. Moreover, studies suggest that some specific changes in gut microbiota 
composition are associated with different diseases [46, 47]. This was confirmed by the 
comparison of the microbiome from healthy individuals with those of diseased individuals, 
allowing the identification of microbiota imbalance in human diseases such as inflammatory 
bowel disease or obesity [48, 49]. 
3. Encapsulation of probiotic living cells 
Encapsulation is often mentioned as a way to protect bacteria against severe environmental 
factors [50, 51].The goal of encapsulation is to create a micro-environment in which the 
bacteria will survive during processing and storage and released at appropriate sites (e.g. 
small intestine) in the digestive tract. The benefits of encapsulation to protect probiotics 
against low gastric pH have been shown in numerous reports [50] and similarly for liquid- 
based products such as dairy products [21, 52]. 
Encapsulation refers to a physicochemical or mechanical process to entrap a substance in a 
material in order to produce particles with diameters of a few nanometres to a few 
millimetres. So, the capsules are small particles that contain an active agent or core material 
surrounded by a coating or shell. Encapsulation shell materials include a variety of 
polymers, carbohydrates, fats and waxes, depending of the core material to be protected, 
and this aspect will be discussed below in the this section. 
The protection of bioactive compounds, as vitamins, antioxidants, proteins, and lipids may 
be achieved using several encapsulation technologies for the production of functional foods 
with enhanced functionality and stability. Encapsulation technologies can be used in many 
applications in food industry such as controlling oxidative reaction, masking flavours, 
colours and odours, providing sustained and controlled release, extending shelf life, etc. In 
the probiotic particular case, these need to be protected during the time from processing to 
consumption of a food product. The principal factors against them need to be protected are: 
 Processing conditions (temperature, oxidation, shear, etc.) 
 Desiccation (for dry food products) 
 Storage conditions (packaging and environment: moisture, oxygen, temperature, etc.) 
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 Degradation in the gastrointestinal tract (low pH in stomach and bile salts in the small 
intestine). 
Encapsulation technology is based on packaging of bioactive compounds in mili-, micro- or 
nano-scaled particles which isolate them and control their release upon applying specific 
conditions. The coating or shell of sealed capsules needs to be semipermeable, thin but 
strong to support the environmental conditions maintaining cells alive, but it can be 
designed to release the probiotic cell in a specific area of the human body. The scientific 
references related with probiotic encapsulation stress the degradation in the gastrointestinal 
tract, more than the processing conditions and the coating material usually employed can 
withstand acidic conditions in the stomach and bile salts form the pancreas after 
consumption. In this way, the protection of the biological integrity of probiotic bacteria is 
achieved during gastro-duodenal transit, achieving a high concentration of viable cells to 
the jejunum and the ileum. 
The selection of the best encapsulation technology for probiotics needs to consider 
numerous aspects in order to guarantee the survival of bacteria during the encapsulation 
process, in storage conditions and consumption, as well as the controlled release in the 
specific desired area of gut. So, there are two important problematic issues considering 
probiotic encapsulation: the size of probiotics which exclude the nanoencapsulation 
technologies and the difficulties to keep them alive. 
In this section the most common techniques used for microencapsulation of probiotics 
will be presented (Sect. 3.1), as well as the most usual microcapsule coating or shell 
materials (Sect. 3.2) and some marketing considerations for their application in food 
products (Sect. 3.3). 
3.1. Main techniques for microencapsulation of probiotics 
3.1.1. Spray-drying 
Spray-drying is a commonly used technique for food ingredients production because it is 
a well-established technique suitable for large-scale, industrial applications. The first 
spray dryer was constructed in 1878 and, thus, it is a relatively old technique compared 
with competing technologies [53]. This technique is probably the most economic and 
effective drying method in industry, used for the first time to encapsulate a flavour in the 
1930s. However, it is not so useful for the industrial production of encapsulated probiotics 
for food use, because of low survival rate during drying of the bacteria and low stability 
upon storage. 
Drying is an encapsulation technique which is used when the active ingredient is dissolve 
in the encapsulating agent, forming an emulsion or a suspension. The solvent is 
commonly a hydrocolloid such as gelatine, vegetable gum, modified starch, dextrin, or 
non-gelling protein. The solution that is obtained is dried, providing a barrier to oxygen 
and aggressive agents [54]. 
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In the spray-drying process a liquid mixture is atomized in a vessel with a single-fluid 
nozzle, a two-fluid nozzle or spinning wheel (depending of the type of spray dryer in use) 
and the solvent is then evaporated by contacting with hot air or other gas. Most of spray 
dryers used in food industry are concurrent in design, i.e. product enters the dryer flowing 
in the same direction as the drying air. The objective is to obtain a very rapid drying and to 
avoid that the temperature of the material dried exceeds the exit air temperature of the 
dryer (Figure 1). 
 
Figure 1. Schematic diagram of a spray-dry encapsulation process and image of a Mini Spray Dryer B-
290 (BÜCHI), available at TECNALIA. 
But also in a concurrent design, the conventional procedure requires to expose cells to high 
temperature and osmotic stresses due to dehydration witch results in relatively high 
viability and activity losses immediately after spraying and most likely also affects storage 
stability. However, some strains survive better than others. And parameters as drying 
temperature and time and shell material have also an important effect. 
Using gelatinised modified starch as a carrier material, O’Riordan obtained good results in 
Bifidobacterium cells encapsulation with an inlet temperature of 100 ºC and oulet 
temperature of 45 ºC. Inlet temperatures of above 60 °C resulted in poor drying and the 
sticky product often accumulated in the cyclone. Higher inlet temperatures (>120 °C) 
resulted in higher outlet temperatures (>60 °C) and significantly reduced the viability of 
encapsulated [55]. The logarithmic number of probiotics decreases linearly with outlet air 
temperature of the spray-drier (in the range of 50 ºC - 80 ºC) [56]. So, the optimal outlet air 
temperature might be as low as possible, enough to assure the drying of the product and to 
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avoid the sticky effect. Alternatively, a second draying step might be applied, using a fluid 
bed or a vacuum oven, for example, due to the optimal survival of probiotics is achieved 
with low water activity. 
The successful spray drying of Lactobacillus and Bifidobacterium have previously reported for 
a number of different strains, including L. paracasei [57, 58], Lactobacillus curvatus [59], L. 
acidophilus [60], L. rhamnosus [61] and Bifdobacterium ruminantium [8]. Specifically, Favaro-
Trindade and Grosso [6] used spray drying to encapsulate B. lactis and L. acidophilus in the 
enteric polymer cellulose acetate phthalate enriched with the fructooligosaccharide 
Raftilose1 (a prebiotic). In this work, the process was also appropriate, especially for B. lactis 
(Bb-12), since for entry temperature of 130 ºC and exit of 75 ºC, the counts in the powder and 
dispersion (feed) were similar; however, the L. acidophilus population showed a reduction of 
two log cycles. The atomization process and encapsulant agent cellulose acetate phthalate 
were effective in protecting these micro-organisms in acidic medium (hydrochloric acid 
solutions pH 1 and 2) during incubation for up to 2 h. In another study, B. longum B6 and B. 
infantis were encapsulated by spray drying, with gelatin, soluble starch, milk and gum 
arabic as encapsulating agents. Bifidobacteria in the encapsulated form showed a small 
reduction in their populations when exposed to acidic media and bile solutions when 
compared with those exposed in the free form. Among the encapsulants tested, gelatin and 
soluble starch were the most effective in providing protection to the micro-organisms in 
acidic medium and milk was the least effective [9]. Desmond and collaborators [57] 
encapsulated L. acidophilus in β-cyclodextrin and gum arabic. They used the spray drying 
process, in which entry and exit temperatures of 170 ºC and 90–85 ºC respectively, and 
observed a reduction of 2 log cycles in the microbial population. However, the 
microencapsulation process extended the shelf-life of the culture. 
On the other hand, the most typical materials used as carrier in probiotic bacteria 
encapsulation are proteins and/or carbohidrates, which may be in the glassy state at storage 
temperatures to minimize molecular mobility and thus degradation. The presence of some 
prebiotics in the encapsulating material show higher count after spray drying for 
Bifidobacterium, depending of the physical properties of the prebiotic compound selected 
(thermoprotector effect, crystalinity, etc.) [62, 63] and a similar effect occurs for Lactobacillus 
bacteria [61, 64]. Some researchers have proposed the addition of thermo-protectants as 
inputs before drying with the intention of improving the resistance to the process and 
stability during storage [65]. In the case of Rodríguez-Huezo and collaborators [63] used a 
prebiotic as encapsulant (‘aguamiel’) and a mixture of polymers composed of concentrated 
whey protein, ‘goma mesquista’ and maltodextrin. It is important to mention that not all the 
compound employees were efficient protectors. In fact, Ross and collaborators [66] reported 
that neither inulin nor polydextrose enhanced probiotic viability of spray-dried probiotics. 
In another study, it was also observed that when quercetin was added together with 
probiotics, the microencapsulation yields and survival rates were lower than for the micro-
organism without quercetin [67]. A lot of other studies have employed of spray-drying 
technology to encapsulate probiotic cells, as noted in the table 1. 
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Table 1. Examples of encapsulated probiotic bacteria by Spray-drying Technology. 
In summary, spray-drying technology offers high production rates at relatively low 
operating costs and resulting powders are stable and easily applicable [73]. However, most 
probiotic strains do not survive well the high temperatures and dehydratation during the 
spray-drying process. Loss of viability is principally caused by cytoplasmatic membrane 
damage although the cell wall, ribosomes and DNA are also affected at higher temperatures 
[74]. It was reported that the stationary phase cultures are more resistant to heat compare to 
cells in exponential growth phase [61].One approach used by a number of researchers to 
improve probiotic survival is the addition of protectants to the media prior to drying. For 
example, the incorporation of thermoprotectants, such as trehalose [75], non-fat milk solids 
and/ or adnitol [76], growth promoting factors including various probiotic/prebiotic 
combinations [77] and granular starch [78] have been shown to improve culture viability 
during drying and storage [79, 80]. 
Microencapsulation by spray-drying is a well-established process that can produce large 
amounts of material. Nevertheless, this economical and effective technology for protecting 
materials is rarely considered for cell immobilization because of the high mortality resulting 
from simultaneous dehydration and thermal inactivation of microorganisms.  
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3.1.2. Spray-cooling 
This process is similar to spray-drying described before in relation with the production of 
small droplets. The principal difference in the spray-cooling process is the carrier material 
and the working conditions related with him. In the case, a molten matrix with low melting 
point is used to encapsulate the bacteria and the mixture is injected in a cold air current to 
enable the solidification of the carrier material.  
It is interesting because the capsules produced in this way are generally not soluble in 
water. However, due the thermal conditions of the process, the spray-cooling is used rarely 
for probiotics encapsulation. As example of successful development, the patent US 5,292,657 
[81] present the spray-cooling of probiotics in molten lipid atomized by a rotary disk in a 
cooling chamber. In any case, the contact time of the probiotics with the melt carrier material 
should remain very sort. 
3.1.3. Fluid-bed agglomeration and coating 
The fluid-bed technology evolved from a series of inventions patented by Dr. Wurster and 
colleagues at the University of Wisconsin Alumni Research Foundation (WARF) between 
1957 and 1966 [82, 83, 84, 85]. These patents are based on the use of fluidising air to provide 
a uniform circulation of particles past an atomising nozzle. This nozzle is used to atomize a 
selected coating material (a melt product or an aqueous solution) which solidifies in a low 
temperature or by solvent evaporation. A proper circulation of the particles is recognised as 
the key to assure that all particles in the fluid-bed achieve a uniform coating. The most 
commonly used techniques are referred to as the bottom-spray (Wurster) fluid-bed process 
and the top-spray fluid-bed process (Figure 2); however, variations such as tangential-spray 
are also practised. 
 
Figure 2. Schematic Diagrams of two types of the most commonly used fluid-bed coaters. 
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The top-spray fluid-bed coater is characterized by placement of nozzle above a fluidising 
bed and spraying down ware into the circulating flow of particles. This technique is useful 
for agglomeration or granulation. As particles flow is spray direction countercurrent, 
collisions involving wet particles are more probable and these collisions agglomerate 
particles. Bur the particles agglomerate become heavier and have less fluidization, so this 
phenomenon selectively agglomerates smaller particles and promotes agglomerate 
uniformity. 
Placement of the nozzle at the bottom of a fluid bed provides the most uniform film on 
small particles and minimises agglomeration of such particles in the coating process 
compared with any other coating technique. This uniform coating is achieved because 
particles move further apart as they pass through the atomised spray from the nozzle and 
into an expansion region of the apparatus. This configuration allows the fluidising air to 
solidify or evaporate coating materials onto particles prior to contact between particles. A 
partition (centre tube) is used in Wurster fluid-bed coating to control the cyclic flow of 
particles in the process better than with de air distribution plate alone (Figure 3). 
 
Figure 3. Expansion chamber for a bottom-spray (Wurster) fluid-bed process and detail of air 
distribution plate (from Glatt available at TECNALIA). 
The most common coating material used for probiotics is lipid based, but proteins or 
carbohydrates can also be used [86]. This technique is among all, probably the most 
applicable technique for the coating of probiotics in industrial productions since it is 
possible to achieve large batch volumes and high throughputs. As example, Lallemand 
commercialize ProbiocapTM, and these particles are made in a fluid bed coating of freeze-
dried probiotics with low melting lipids [87]. 
Specifically, Koo and collaborators [88], reported that L. bulgaricus loaded in chitosan-coated 
alginate microparticles showed higher storage stability than free cell culture. Later, Lee and 
researchers [69] showed that the microencapsulation in alginate microparticules coating 
with chitosan offers an effective way of delivering viable bacterial cells to the colon and 
maintaining their survival during refrigerated storage. 
 
Probiotics 510 
Fluidized-bed drying was recently investigated by Stummer and collaborators [89] as 
method for dehydration of Enterococus faecium. This study concludes to use fluidized-bed 
technology as a feasible alternative for the dehydration of probiotic bacteria by layering the 
cells on spherical pellets testing different protective agents as glucose, maltodextrin, skim 
milk, trehalose or sucrose, preferably skim milk or sucrose. According with the described 
procedure, it is possible to combine two manufacturing steps: (1) cell-dehydration 
preserving the optima cell properties and (2) the processing into suitable solid formulation 
with appropriate physical properties (the spherical pellets improve the flowability for filling 
capsules or dosing in different formulations.) 
3.1.4. Freeze and vacuum-drying 
Freeze-drying is also named lyophilisation. This drying technique is a dehydration process 
which works by freezing the product and then reducing the surrounding pressure to allow 
the frozen water to sublimate directly from the solid phase to the gas phase. The process is 
performed by freezing probiotics in the presence of carrier material at low temperatures, 
followed by sublimation of the water under vacuum. One of the most important advantages 
is the water phase transition and oxidation are avoided. In order to improve the probiotic 
activity upon freeze-drying and also stabilize them during storage, it is frequent the 
addition of cryoprotectans. 
One of the most important aspects to decide is the choice of the optimal ending water 
content. This decision have to be a compromise between the highest survival rate after 
drying (higher survival rate with higher water content) and the lowest inactivation upon 
storage (better at low water activity, but not necessarily 0% of water content). According 
with King and collaborators [90], the loses in survival rates of freeze-dried probiotic bacteria 
under vacuum may be explained with a first-order kinetic and the rate constants can be 
described by an Arrhenius equation. But this equation might be affected by other factors as 
phase transition, atmosphere and water content. 
In any case, the lyophilisation or freeze-drying is a very expensive technology, significantly 
more than spray-drying [56], even if it is probably most often used to dry probiotics. 
However, most of freeze-drying process only provide stability upon storage and not or 
limited during consumption. Because of that, this technique is used as a second step of 
encapsulation process. The freeze-drying is useful to dry probiotics previously encapsulated 
by other different techniques, as emulsion [91] or entrapment in gel microspheres [92]. In 
this way it is possible to improve the stability in the gastrointestinal tract and optimize the 
beneficial effect of probiotic consumption. 
The Vacuum-drying is a similar process as freeze-drying, but it takes place at 0 - 40 ºC for 30 
min to a few hours. The advantages of this process are that the product is not frozen, so the 
energy consumption and the related economic impact are reduced. In the product point of 
view, the freezing damage is avoided.  
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3.1.5. Emulsion-based techniques 
An emulsion is the dispersion of two immiscible liquids in the presence of a stabilizing 
compound or emulsifier. When the core phase is aqueous this is termed a water-in-oil 
emulsion (w/o) while a hydrophobic core phase is termed an oil-in-water emulsion (o/w). 
Emulsions are simply produced by the addition of the core phase to a vigorously stirred excess 
of the second phase that contains, if it is necessary, the emulsifier (Figure 4). Nevertheless, 
even if the technique readily scalable, it produce capsules with an extremely large size 
distributions. Because of this limitation, there are several industrial efforts to achieve a narrow 
particle size distribution controlling the stirring and homogenization of the mixture. 
There are also double emulsions, such water-in-oil-in-water (w/o/w). The technique is a 
modification of the basic technique in which an emulsion is made in of an aqueous solution 
in a hydrophobic wall polymer. This emulsion is the poured with vigorous agitation, into an 
aqueous solution containing stabilizer. The loading capacity of the hydrophobic core is 
limited by the solubility and diffusion to the stabilizer solution. The principal application of 
this technology is in pharmaceutical formulations. 
Entrapment of probiotic bacteria in emulsion droplets has been suggested as a means of 
enhancing the viability of microorganism cells under the harsh conditions of the stomach 
and intestine. For example, Hou and collaborators [93] reported that entrapment of cells of 
lactic bacteria (Lactobacillus delbrueckii ssp. bulgaricus) in the droplets of reconstituted sesame 
oil body emulsions increased approximately 104 times their survival rate compared to free 
cells when subjected to simulated GI tract conditions. 
 
Figure 4. Probiotic cell encapsulation by water-in-oil and water-in-oil-in-water emulsions. 
Nevertheless, Mantzouridou and collaborators [94] have presented an study investigating the 
effect of cell entrapment inside the oil droplets on viable cell count over storage and under GI 
simulating conditions, according to the type of emulsifier used: egg yolk, gum arabic/xanthan 
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mixture or whey protein isolate. The study was performed with Lactobacillus paracasei and 
their entrapment in the oil phase of protein-stabilized emulsions protected the cells when 
exposed to GI tract enzymes, provided that the emulsions were freshly prepared. Following, 
however, treatment of aged for up to 4 weeks emulsions under conditions simulating those of 
the human GI environment, the microorganism did not survive in satisfactory numbers. The 
probiotic cells survived in larger numbers in aged emulsions when the cells were initially 
dispersed in the aqueous phase of a yolk-stabilized dressing-type emulsion and their ability 
to survive enzymatic attack was further enhanced by inulin incorporation. 
Table 2. Examples of encapsulated probiotic bacteria by Emulsification Technology. 
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Lactobacillus rhamnosus has been encapsulated in a w/o/w emulsion. According to Pimentel-
González and collaborators [95] the survival of the entrapped L.rhamnosus in the inner water 
phase of the double emulsion increased significantly under low pH and bile salt conditions 
in an in vitro trial, meanwhile the viability and survival of control cells decrease significantly 
under the same conditions. 
In the table 2 details probiotic strains and carrier materials that have employed some 
researchers in the emulsification technology. 
The emulsion methods produce capsules sized from a few micrometres to 1mm, 
approximately, but with a high dispersion compared to other techniques, as extrusion ones. 
Moreover, even if the emulsion techniques described before are easily scalable, these 
techniques have an important disadvantage to be applied in an industrial process because 
are batch processes. Nevertheless, it exist another promising technique different to the 
turbine used. The static mixers are small devices placed in a tube consisting in static 
obstacles or diversions where the two immiscible fluids are pumped [118, 119]. This system 
improves the size distribution, reduce shear and allows keeping the aseptic conditions 
because it might be a closed system (Figure 5). For example, nowadays this technology is 
used in dairy industry for viscous products, as admixing fruit pieces or cultures to yoghurt 
or to process ice cream or curds. 
 
Figure 5. Schematic diagram of a static mixer system to make emulsions. 
3.1.6. Coacervation 
This process involves la precipitation of a polymer or several polymers by phase separation: 
simple or complex coacervation, respectively. Simple coacervation is based on “salting out” 
of one polymer by addition of agents as salts, that have higher affinity to water than the 
polymer. It is essentially a dehydration process whereby separation of the liquid phase 
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results in the solid particles or oil droplets (starting in an emulsion process) becoming 
coated and eventually hardened into microcapsules. With regard to complex coacervation, it 
is a process whereby a polyelectrolyte complex is formed. This process requires the mixing 
of two colloids at a pH at which both polymers are oppositely charged (i.e. gelatine (+) and 
arabic gum (-)), leading to phase separation and formation of enclosed solid particles or 
liquid droplets. 
The complex coacervation is one of the most important techniques used for flavour 
microencapsulation. But it is not the only use of this technique and the complex 
coacervation is also suitable for probiotic bacteria microencapsulation. And the most 
frequent medium used might be a water-in-oil emulsion [120]. 
Oliveira and collaborators [121] encapsulated B. lactis (BI 01) and L. acidophilus (LAC 4) 
through complex coacervation using a casein/pectin complex as the wall material. To ensure 
higher stability, the coacervated material was atomized. The process used and the wall 
material were efficient in protecting the microorganisms under study against the spray 
drying process and simulated gastric juice; however, microencapsulated B. lactis lost its 
viability before the end of the storage time. Specifically, microencapsulated L. acidophilus 
maintained its viability for a longer storage (120 days) at 7 and 37 ºC, B. lactis lost viability 
quickly. 
Advantages of coacervation, compared with other methods for the encapsulation of 
probiotics, are a relatively simple low-cost process (which does not necessarily use high 
temperatures or organic solvents) and allow the incorporation of a large amount of micro-
organisms in relation to the encapsulant. However, the scale-up of coacervation is difficult, 
since it is a batch process that yields coacervate in an aqueous solution. Therefore, to extend 
its shelf-life, an additional drying process should be applied, which can be harmful to cells. 
3.1.7. Extrusion techniques to encapsulate in microspheres 
The methods of bioencapsulation in microspheres include two principal steps: (1) the 
internal phase containing the probiotic bacteria is dispersed in small drops a then (2) these 
drops will solidify by gelation or formation of a membrane in their surface. Before this 
section, there are described emulsion systems and coacervation as different methods to 
obtain these drops and even the membrane formation, but also extrusion technology is 
useful in order to produce probiotic encapsulation in microspheres. There are different 
technologies available for this purpose and the selection of the best one is related with 
different aspects as desired size, acceptable dispersion size, production scale and the 
maximum shear that the probiotic cells can support. 
When a liquid is pumped to go through a nozzle, first this is extruded as individual drops. 
Increasing enough the flow rate, the drop is transformed in a continuous jet and this 
continuous jet has to be broken in small droplets. So, the extrusion methods could be 
divided in two groups, dropwise and jet breakage (Figure 6), and the limit between them is 
established according to the minimum jet speed according to this equation (eq. 1): 
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Regardless of the selected technique, the liquid obtained drops have to be solidifying by 
gelation or external membrane formation (Figure 6). The resulting hydrogel beads are very 
porous and a polymeric coating is usually applied in order to assure a better retention of the 
encapsulated probiotic bacteria. 
 
Figure 6. Classification of methods to make and solidify drops 
 Dripping by gravity 
This method is the simplest dripping method to make individual drops, but the size of the 
droplet will be determined by his weight and surface tension, as well as the nozzle 
perimeter. The typical diameter of a drop made by this technique is higher than 2 mm. 
Moreover, the flow is around several millilitres by hour and the method is not interesting 
for an industrial application. For example, in the Figure 7 is showed a cell immobilization 
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process carried out at TECNALIA using the method of dripping by gravity. The nozzle 
diameter is 160 μm and the final size of hydrogel bead (after solidification in a Calcium 
Chloride solution) is 2,4±0,15 mm. 
 
Figure 7. Cell encapsulation in an alginate matrix. Drop generation by gravity using a 160 μm nozzle. 
 Air o liquid coaxial flow and submerged nozzles 
Applying a coaxial air flow around the extrusion nozzle it is possible to reduce the 
microsphere diameter between a few micrometres and 1 mm. However, the flow rate is 
limited, less than 30 mL/h to avoid a continuous jet formation. The air flow might be 
replaced for a liquid one: with a suitable selection of the liquid flow the control of the 
surface tension is improved. Drops produced in air are generated as aerosols, while the 
drops produced, for example, in water are made as emulsions. The aerosol beads could be 
solidified using ionic gelation or hot air. The beads recovered as emulsion are usually 
extracted or the water is evaporated. 
The Spanish enterprise Ingeniatrics Tecnologías has patent an owner Flow Focusing® 
technology, valid to work with air and liquid flow, and also an user-friendly 
bioencapsulation device for biotechnological research and clinical microbiology able to 
encapsulate high molecular weight compounds, microorganisms and cells in homogeneous 
particles of predictable and controllable size based on Flow Focusing® technology named 
Cellena® distributed by Biomedal (Figure 8). 
Nevertheless, despite all the advantages, due to the mentioned low flow rate, this technique 
is not used in an industrial scale and also in a laboratory scale it is being replaced for the jet 
breakage techniques stated below. 
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Figure 8. Flow-Focusing technology to make droplets and Cellena® equipment from Ingeniatrics 
Tecnologías. 
The submerged nozzles usually are static, but they can be also rotating or vibrating to 
improve the droplet generation, but are always immersed in a carrier fluid. An example of 
the former consist of a static cup immersed in a water-immiscible oil such as mineral oil or 
vegetal oil and a concentric nozzle as is schematically showed in the Figure 9. Each droplet 
consist of core material being encapsulatd totally surrounded by a finite film of aqueous 
polymer solution, as gelatine, for example. The carrier fluid, a warm oil phase that cools 
after droplet formation, gels this polymer solution thereby forming gel beads with a 
continuous core/shell structure. The smaller diameter using this technique is typically 
around 1 mm. 
 
Figure 9. Schematic diagram of a submerged two-fluid static nozzle. 
An example of this technology is provided by Morishita Jintan Co. Ltd in Japan These 
capsules are composed of three layers: a core freeze-dried probiotic bacteria in solid fat, with 
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an intermediate hard fat layer and a gelatin-pectin outer layer [122]. However, the size of the 
capsules produced is quite large to be applied in food products (1.8-6.5 mm) and the 
technique is quite expensive for use in many food applications. 
 Electrostatic potential 
This technique is the last one of drop generation techniques. The droplet generation 
improves replacing the dragging forces by a high electrostatic potential between the 
capillary nozzle and the harvester solution. The electric forces help the gravity force in front 
of the surface tension.  
Even if the capsules size is appropriated and the size distribution is narrow enough, this 
technique is more expensive than other extrusion ones and it is not fast enough to be scaled. 
 Vibration technology for jet break-up 
Applying a vibration on a laminar jet for controlled break-up into monodisperse 
microcapsules is one among different extrusion technologies for encapsulation of probiotic 
bacteria. The vibration technology is based on the principle that a laminar liquid jet breaks 
up into equally sized droplets by a superimposed vibration (Figure 10). The instability of 
liquid jets was theoretically analysed for Lord Rayleigh [123]. He showed that the frequency 
for maximum instability is related to the velocity of the jet and the nozzle diameter (eq. 2 
and eq. 3). 
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Using this technology, it is possible to obtain monodisperse droplets which size can be 
freely chosen in a certain range depending on the nozzle diameter and the frequency of the 
sinusoidal force applied (eq. 4). The droplets made are harvested in an accurate hardening 
bath. To avoid large size distributions due to coalescence effects during the flight and the 
hitting phase at the surface of hardening solution the use of a dispersion unit with an 
electrostatic dispersion unit is essential (Figure 10). 
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Figure 10. Image of Inotech Encapsulator IE-50R and schematic diagram of jet destabilization and 
breakage for single and concentric nozzles. 
The Encapsulator BIOTECH (the updated version of IE-50R) from EncapBioSystems and 
Spherisator form BRACE GmbH are two different devices labels to produce 
microencapsuled probiotic bacteria using the vibration technology for jet breakage. The 
principal advantages of this technology are the low size dispersion (5-10%), a high flow rate 
(0.1-2 L/h) and is able to work in sterile conditions. The possibility of working with a wide 
range of materials (hot melt products, hydrogels, etc.) is also an important aspect to be 
considered, as well as the design with also concentric nozzles in the lab scale devices and 
with this kind of nozzles it is possible to produce capsules with a defined core region (solid 
or liquid) surrounded by a continuous shell layer. On the other side, the principal 
disadvantage of this technology is the limit in the viscosity for the liquid to be extruded. 
But may be one of the most important advantage of the vibration devices commercialized is 
that the scale up of this technology is relatively “simple” and it consist in the multiplication 
of the number of nozzles, developing multinozzle devices. The only challenge is that each 
nozzle of a multinozzle plant must operate in similar production conditions: equal 
frequency and amplitude, and equal flow rate. In this way, the scale up is direct from the lab 
to a pilot or industrial scale. 
 JetCutter technology 
The bead production by JetCutter (from geniaLab) is achieved cutting a jet into cylindrical 
segments by a rotating micrometric cutting tool. The droplet generation is based on a 
mechanical impact of the cutting wire on the liquid jet. Some techniques as emulsion, simple 
dropping, electrostatic-enhanced dropping, vibration technique or rotating disc and nozzle 
techniques have in common that the fluids have to be low in viscosity, and not all of them 
may be used for large-scale applications. On the contrary, the JetCutter technique is 
especially capable of processing medium and highly viscous fluids up to viscosities of 
several thousand mPas. 
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For bead production by the JetCutter the fluid is pressed with a high velocity out of a nozzle 
as a solid jet. Directly underneath the nozzle the jet is cut into cylindrical segments by a 
rotating cutting tool made of small wires fixed in a holder (Figure 11). Driven by the surface 
tension the cylindrical segments form spherical beads while falling further down, where 
they finally can be harvested. The size of beads can be adjusted within a range between 
approximately 200 μm up to several millimetres, adjusting parameters as nozzle diameter, 
flow rate, number of cutting wires and the rotating speed of cutting tool. 
Bead generation by a JetCutter device is achieved by the cutting wires, which cut the liquid 
jet coming out of the nozzle. But in each cut the wire produce a cutting loss. The device is 
designed to recover these losses, but it is important to minimize de lost volume selecting a 
smaller diameter of the cutting wire and angle of inclination of the cutting tool with regard to 
the jet (Figure 11). According with Pruesse and Vorlop [124], a suitable model of the cutting 
process might help to operator in the parameters selection. One of the most important 
parameters is the ratio of the velocities of the fluid and cutting wire, necessary to determinate 
the proper inclination angle (eq. 5), but the fluid velocity is also related with the bead size (eq. 
6), while the diameter of the nozzle and wire determine the volume of cutting loses (eq. 7). 
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Regarding the advantages of the JetCutter technology, besides the capacity for work with 
medium and highly viscous fluids, there are the narrow bead size dispersion and the wide 
range of possible sizes, as well as the high flow rate (approx. 0.1-5 L/h). 
To scale up the JetCutter technology there are two ways. First, a multi-nozzle device can be 
used, in which nozzles are strategically distributed in the perimeter of the cutting tool. The 
second way is the increase of the cutting frequency, but this approach needs also a higher 
velocity of the jet and a too high speed of the beads might cause problems, as coalescence or 
deformation in the collection bath entrance. In order to overcome this problem, the droplets 
can be pre-gelled prior entering the collection bath using, for example, a tunnel equipped 
with nozzles spraying the hardening solution or refrigerating the falling beads. 
The extrusion technique is the most popular microencapsulation or immobilization technique 
for micro-organisms that uses a gentle operation which causes no damage to probiotic cells 
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and gives a high probiotic viability [21]. This technology does not involve deleterious 
solvents and can be done under aerobic and anaerobic conditions. The most important 
disadvantage of this method is that it is difficult to use in large scale productions due to the 
slow formation of the microbeads [15]. Various polymers can be used to obtain capsules by 
this method, but the most used agents are alginate, -carrageenan and whey proteins [125]. 
 
Figure 11. Schematic diagram of the JetCutter technology and representation of fluid losses due to the 
cutting wire impact. 
 
Figure 12. Examples of two bioencapsulation process carried out at TECNALIA changing the nozzle 
diameter, cutting tool and inclination angle to obtain different bead size necessaries for several 
applications. 
There are many studies with the extrusion techniques for probiotic protection and 
stabilization. In 2002, Shah and Ravula [126] encapsulated Bifidobacterium and Lactobacillus 
acidophilus in calcium alginate in frozen fermented milk-based dessert, and, in general, the 
survival of bacteria cells was improved by encapsulation. Some studies employed to 
encapsulate Bifidobacteria alginate alone and a mixture with other compounds and 
observed more resistant to the acidic medium than the free cells [5, 112, 127]. A similar 
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result was observed by Chávarri and collaborators [67], where chitosan was used as coating 
material to improve the stability of alginate beads with probiotics. In this study, with 
extrusion technique, they showed an effective means of maintaining survival under 
simulated human gastrointestinal conditions. In the table 3 details probiotic strains and 
carrier materials that have employed some researchers in the extrusion technology. 
Table 3. Examples of encapsulated probiotic bacteria by Extrusion Technology. 
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3.1.8. Adhesion to starch granules 
Starch is unique among carbohydrates because it occurs naturally as discrete particles called 
granules. Their size depends on the starch origin ranging from 1 to 100 μm. They are rather 
dense and insoluble, and hydrate only slightly in water at room temperature. The granular 
structure is irreversibly lost when the granules are heated in water about 80 ºC, and heat 
and mechanical energy are necessaries to totally dissolve the granules. 
Usually starches are partially or totally dissolved before they are used in food application, 
for example to be used as texturizing. Starch hydrolysates or chemically modified starches 
are used as microencapsulation matrices for lipophilic flavours [152, 153]. Partially 
hydrolysed and crosslinked starch granules were suggested to be suitable carriers for 
various functional food components [154]. To hydrolyse the starch granules, the use of 
amylases is the preferred way and corn starch seems to be the most suitable starch for his 
purpose. 
Some probiotic bacteria were shown to be able to adhere to starch and a few investigations 
about the utilisation of starch granules to protect these bacteria were reported. 
3.1.9. Compression coating 
This technique involves compressing dried bacteria powder into a core tablet or pellet and 
the compressing coating material around the core to form the final compact (Figure 13). The 
compression coating has received a renewed interest for probiotic bacteria encapsulation 
used with gel-forming polymers in order to improve the stabilization of lyophilized bacteria 
during storage [155]. The viability in process of the bacteria is affected by the compression 
pressure and to improve the storage survival the coating material has a significant effect. 
Due of the size of the final product obtained by compression coating, this technique is used 
for pharmaceutical and nutraceutical compounds development, but not for food ingredients 
obtention. 
 
Figure 13. Schematic diagram of compression coating of probiotics. 
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3.2. Shell or carrier encapsulation materials 
Microcapsules should be water-insoluble to maintain their structural integrity in the food 
matrix and in the gastrointestinal tract. The materials are used alone or in combination to 
form a monolayer. In this last case, coating the microcapsule with the double membrane can 
avoid their exposure to oxygen during storage and can enhance the resistance of the cells to 
acidic conditions and higher bile salt concentrations. 
3.2.1. Ionic hydrogels 
 Alginate  
Alginate is surely the biopolymer most used and investigated for encapsulation. Alginates 
are natural occurring marine polysaccharides extracted from seaweed, but also they occur as 
capsular polysaccharides in some bacteria [156]. Being a natural polymer, alginic acids 
constitute a family of linear binary copolymers of 1-4 glycosidically linked α-L-guluronic 
acid (G) and its C-5 epimer β-D-mannuronic acid. (M). Alginates are the salts (or esters) of 
these polysaccharides. They are composed of several building blocks (100-3,000 units) liked 
together in a stiff and partly flexible chain. The relative amounts of the two uronic units and 
the sequential arrangements of them along the polymer chain vary widely, depending of the 
origin of the alginate: three types of blocks may be found: homopolymeric M-blocks (M-M), 
homopolymeric G-blocks (G-G) and heteropolymeric sequentially alternating MG-blocks 
(M-G). This composition and block structure are strongly related to the functional properties 
of alginate molecules within an encapsulation matrix.  
Immobilisation or entrapment of probiotic bacteria in alginate it is possible due to it is a 
rapid, non-toxic and versatile method for cells. Dissolving alginate in water gives a viscous 
solution of which the viscosity will increase with the length of the macromolecule (number 
of monomeric units), and its solubility is also affected by the pH (at pH < 3 precipitate as 
alginic acid), the presence of counterions in water (alginate precipitates by crosslinking, 
gelling, with divalent ions such as Ca2+, Ba2+, Sr2+…) and the sequential arrangements of the 
monomers (the flexibility of the alginate chains in solution increases in the order 
MG<MM<GG). The gelling occurs when a cation as Ca2+ take part in the interchain binding 
between G-bloks giving rise to a three-dimensional network (Figure 14). 
The advantage of alginate is that easily form gel matrices around bacterial cells, it is safe to 
the body, they are cheap, mild process conditions (such as temperature) are needed for their 
performance, can be easily prepared and properly dissolve in the intestine and release 
entrapped cells. However, some disadvantages are attributed to alginate beads. For 
example, alginate microcapsules are susceptible to the acidic environment [136] which is not 
compatible for the resistance of the beads in the stomach conditions. Other disadvantage of 
alginate microparticle is that the microbeads obtained are very porous to protect the cells 
from its environment [157]. Nevertheless, the defects can be compensated by blending of 
alginate with other polymer compounds, coating the capsules by another compound or 
structural modification of the alginate by using different additives [21]. 
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Figure 14. Gelation of an alginate bead when the Ca2+ gelling ions diffuse into the alginate-containing 
system. 
 Chitosan 
Chitosan is a deacetylated derivative of chitin, which is widely found in crustacean shells, 
fungi, insects and molluscs. This polymer is a linear polysaccharide, which can be 
considered as a copolymer consisting of randomly distributed β-(1,4) linked D-glucosamine 
and N-acetyl-D-glucosamine. The functional properties of chitosan are determined by the 
molecular weight, but also by the degree of acetylation (DA), which represents the 
proportion of N-acetyl-D-glucosamine units with respect to the total number of units [158]. 
Chitosan is soluble in acidic to neutral media, but solubility and viscosity of the solution is 
dependent on the length of chains and the DA.  
As chitosan is a positively charged polymer, it forms ionic hydrogels by addition of anions 
such as pentasodium tripolyphosphate (TPP) and also by interaction with negatively 
charged polymers as alginate [67] or xanthan [159]. It is possible to obtain an hydrogel by 
precipitation in a basic medium or by chemical crosslinking with glutaraldehyde [160]. 
 
Figure 15. Chitosan microcapsules obtained by (left) TTP crosslinking using the IE-50R and size 
distribution of the particles, and (right) spray-dryer (TECNALIA). 
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Chitosan is biodegradable and biocompatible. Nevertheless, to be used in probiotic bacteria 
encapsulation it is necessary to consider the antibacterial activity of this polymer. Due the 
possibility of a negative impact in the viability of bacteria, and due that chitosan has a very 
good film-forming ability, chitosan is more used as external shell in capsules made with 
anionic polymers as alginate. This application of chitosan can improve the survival of the 
probiotic bacteria during storage and also in the gastrointestinal tract [67, 161, 162], and 
therefore, it is a good way of delivery of viable bacterial cells to the colon [67]. 
3.2.2. Thermal hydrogels 
 Gellan gum 
Gellan gum is a high molar mass anionic polyelectrolyte produced as an aerobic 
fermentation product by a pure culture of Pseudomonas elodea [163]. The chemical structure 
of gellan gum shows a tetrasaccharide repeating unit composed of one rhamnose, one 
glucoronic acid and two glucose units. It is possible to induce a thermo-reversible gelation 
upon cooling of gellan gum solutions and the gelation temperature will depend on the 
polymer concentration, ionic strength and type of counterions presents in the medium. The 
gels of gellan gums with low acyl content need the presence of divalent stabilizing cations 
[164]. 
Although gellan gum is able to generate gel-bead structure for microencapsulation, a 
disadvantage is that it is not used in this way for this purpose because of having a high gel-
setting temperature (80-90°C for about 1 h) which results in heat injuries to the probiotic 
cells [129]. 
 Xanthan 
Xanthan is a heteropolysaccharide with a primary structure consisting of repeated 
pentasaccharide units formed by two glucose units, two mannose units and one glucoronic 
acid unit. The polysaccharide is produced by fermentation of bacterium Xanthomonas 
campestris and posterior filtration or centrifugation. This polymer is soluble in cold water 
and hydrates rapidly. Even if xanthan is considered to be mainly non-gelling a mixture of 
both, xanthan and gellan gum has been used to encapsulate probiotic cells [19, 102] and 
contrary to alginate, the mixture presents high resistance towards acid conditions. 
In contrary with alginate, mixture of xanthan-gellan is resistant to acidic conditions. Also, as 
opposed to from carrageenan which needs potassium ions for structural stabilization (it is 
harmful for the body in high concentrations), this gum can be stabilized with calcium ions 
[165, 166]. 
 Carrageenan 
Carrageenans are a family of high molecular weight sulphated polysaccharides obtained 
from different species of marine red algae. The most frequently used is -carrageenan, 
opposite to - or -carrageenan. This polymer is largely used as thickening, gelling agent, 
texture enhancer or stabilizer on food, pharmaceutical and cosmetic formulations. His 
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primary structure is based on an alternating disaccharide repeating unit of α-(1,3)--
galactose-4-sulphate and -(1,4)-3,6-anhydro--galactose.  
-carrageenan requires high temperatures (60-90 ºC) for dissolution, especially when 
applied at high concentrations such as 2-5%. However, this material used for encapsulating 
probiotics requires a temperature comprised between 40 and 50 ºC at which the cells are 
added to the polymer solution. It forms thermoreversible gels by cooling in presence of K+ as 
stabilizing ions. The gelation with divalent cations as Ca2+ or Cu2+ is also possible, but not so 
often used and the thermal gelation is the most common method [167, 168]. 
The -carrageenan beads for probiotic encapsulation can be produced using several 
technologies described in the extrusion as well as emulsion techniques. 
The encapsulation of probiotic cells in -carrageenan beads keeps the bacteria in a viable 
state [96] but the produced gels are brittle and are not able to withstand stresses [19]. 
 Gelatin 
Gelatin is a heterogeneous mixture of single or multi-stranded polypeptides, each with 
extended left-handed proline helix conformations and containing between 300 and 4,000 
amino acid units. Gellatines generally have a characteristic primary structure determined by 
the parent collagen, because they are a irreversible hydrolysed form of collagen obtained 
from the skin, boiled crushed bones, connective tissues, organs and some intestines of 
animals. However they vary widely in their size and charge distribution and there are two 
types of gelatines depending on the treatment to obtain the gelatine: type-A gelatine is 
obtained from acid treated raw material and type-B gelatine is obtained from alkali treated 
one. 
Gelatine is water-soluble, but the solutions have high viscosity and it forms a thermal 
hydrogel who melts to a liquid when heated and solidifies when cooled again. Gelatine gels 
exist over only a small temperature range, the upper limit being the melting point of the gel, 
which depends on gelatine grade and concentration (but is typically less than 35 °C) and the 
lower limit the freezing point at which ice crystallizes.  
This material is useful to obtain beads using extrusion technologies or form a w/o emulsion 
by cooling, but to stabilize the gel the beads may need to be crosslinked using 
glutaraldehyde or salts of Chrome. In fact, it is largely used in complex coacervation 
technique combined with anionic polysaccharides such as arabic gum and others. The most 
important consideration is that both hydrocolloids have to be miscible at an appropriate pH 
to stabilize their charges and avoid the repulsion between similar charged groups. 
3.2.3. Milk protein gel 
Just like the gelatine, milk proteins are able to form gels in the suitable conditions. Proteins 
are chains of amino acid molecules connected by peptide bonds and there are may types of 
proteins due the high number of amino acids (22 units) and the different possibility of 
sequences. Among other proteins, milk proteins are very interesting as encapsulation 
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material by their physic-chemical properties. There are two major categories of mil protein 
that are broadly defined by their chemical composition and physical properties. The caseins 
are proline-rich, open-structured rheomorphic proteins which have distinct hydrophobic 
and hydrophilic parts and 95% of caseins are naturally self-assembled into casein micelles. 
Whey proteins primarily include α-lactalbumin, β-lactoglobulin, immunoglobulins, and 
serum albumin, but also numerous minor proteins, but whey proteins are globular ones. 
Milk proteins are natural vehicles for probiotics cells and owing to their structural and 
physico-chemical properties, they can be used as a delivery system [169]. For example, the 
proteins have excellent gelation properties and this specificity has been recently exploited 
by Heidebach and collaborators [170, 171] to encapsulate probiotic cells. The results of these 
studies are promising and using milk proteins is an interesting way because of their 
biocompatibility [169]. 
3.2.4. Starch 
Starch is a polysaccharide composed by α-D-glucose units linked by glycosidic bonds, 
produced by all green plants. It consist of two constitutionally identical but architecturally 
different molecules: amylose and amylopectin. The amylose is the linear and helical chains 
of glucose polymer, while the amylopectin is the highly branched chains. The content of 
each fraction depends of the starch origin, but in general it contains around 20-30% amylose 
and 70-80% amylopectin. 
 
Figure 16. Coloured maltodextrin microcapsules obtained by spray-drying (TECNALIA). 
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As it is described in the previous section, the probiotic bacteria can be encapsulated by adhesion 
to starch granules, but usually the starch is chemical or physically modified for different 
applications, even encapsulation as maltodextrins or cyclodextrins commonly used in 
combination with the spray-drying technology (Figure 16), fluid bed granulation, for examples. 
Starch granule is an ideal surface for the adherence of the probiotics cells and the resistant 
starch (the starch which is not digested by pancreatic enzymes in the small intestine) can 
reach the colon where it is fermented [172]. Therefore, the resistant starch provides good 
enteric delivery characteristic that is a better release of the bacterial cells in the large 
intestine. Moreover, by its prebiotic functionality, resistant starch can be used by probiotic 
bacteria in the large intestine [173, 174]. 
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